In an environment of rapidly evolving trade conditions, understanding the nuances of index performance across countries is ...

Falling rates and loan maturities impact Ames National's net interest margins, dividends, and growth amidst tariff uncertainty. See more on ATLO stock here.

Arcutis Biotherapeutics' Zoryve drives revenue growth and nears cash flow positivity, yet high valuation warrants a Hold rating. Read more on ARQT stock here.

Chevron ordered to pay $744M to restore damage caused to Louisiana's coastal wetlands, and said it expects to cut ~600 jobs in San Ramon, California, and ~700 in downtown Houston by year-end ...

The S&P 500 lost more than $4T in market capitalization this week, as investors spooked by the Trump administration’s import tariffs drove the market benchmark into a ...

JPMorgan on Friday updated its U.S. economic outlook and now sees the country slipping into a recession in 2025. Read more ...

Medicare delays decision on obesity drug coverage, impacting millions of seniors and big weight-loss drugmakers like Eli ...

Under Armour, Inc. navigates tariff challenges while leveraging premium products & strong finances. Click for my updated look ...

Mitsubishi Corporation's short-term prospects are unfavorable with an expected large decline in earnings for the new fiscal ...

Tesla, Inc. stock faces short-term challenges but holds strong long-term potential with its robotaxi program and robotics ...

Trump's new tariffs impact Apple Inc.'s supply chain, earnings, and valuation. Click here to find out why AAPL stock is a ...

UnitedHealth (UNH) and Cigna (CI) are under pressure as the FTC looks to resume a lawsuit against their PBMs. Read more here.